Novel links among Wnt and TGF-βsignaling and Runx2

Molecular Endocrinology

Volumn 24, Issue 3, 2010, Pages 587-597

  McCarthy, Thomas L ^a   Centrella, Michael ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL FACTOR; LYMPHOID ENHANCING FACTOR 1; MESSENGER RNA; PROSTAGLANDIN E2; PROTEIN TCF4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE REPRESSION; IN VITRO STUDY; MOLECULAR INTERACTION; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; REGULATORY MECHANISM; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BETA CATENIN; BLOTTING, WESTERN; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; LYMPHOID ENHANCER-BINDING FACTOR 1; OSTEOBLASTS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEINS;

EID: 77249174394     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2009-0379     Document Type: Article

References (58)

1. MacDonald BT, Tamai K, He X 2009 Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev Cell 17:9-26
2. Zhang Y, Wang Y, Li X, Zhang J, Mao J, Li Z, Zheng J, Li L, Harris S, Wu D 2004 The LRP5 high-bone-mass G171V mutation disrupts LRP5 interaction with Mesd. Mol Cell Biol 24:4677-4684
3. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass II DA, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L 2002 Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157:303-314
4. Hoang BH, Kubo T, Healey JH, Sowers R, Mazza B, Yang R, Huvos AG, Meyers PA, Gorlick R 2004 Expression of LDL receptor-related protein 5 (LRP5) as a novel marker for disease progression in high-grade osteosarcoma. Int J Cancer 109:106-111
5. Takada I, Mihara M, Suzawa M, Ohtake F, Kobayashi S, Igarashi M, Youn MY, Takeyama K, Nakamura T, Mezaki Y, Takezawa S, Yogiashi Y, Kitagawa H, Yamada G, Takada S, Minami Y, Shibuya H, Matsumoto K, Kato S 2007 A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-γ transactivation. Nat Cell Biol 9:1273-1285
6. Glass II DA, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, Karsenty G 2005 Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8:751-764
7. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, et al. 2001 LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513-523
8. Bennett CN, Longo KA, Wright WS, Suva LJ, Lane TF, Hankenson KD, MacDougald OA 2005 Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci USA 102:3324-3329
9. Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, Schütz G, Glorieux FH, Chiang CY, Zajac JD, Insogna KL, Mann JJ, Hen R, Ducy P, Karsenty G 2008 Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135:825-837
10. Holmen SL, Giambernardi TA, Zylstra CR, Buckner-Berghuis BD, Resau JH, Hess JF, Glatt V, Bouxsein ML, Ai M, Warman ML, Williams BO 2004 Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. J Bone Miner Res 19: 2033-2040
11. Mani A, Radhakrishnan J, Wang H, Mani A, Mani MA, Nelson-Williams C, Carew KS, Mane S, Najmabadi H, Wu D, Lifton RP 2007 LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315:1278-1282
12. Gregory CA, Singh H, Perry AS, Prockop DJ 2003 The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J Biol Chem 278:28067-28078
13. Li J, Sarosi I, Cattley RC, Pretorius J, Asuncion F, Grisanti M, Morony S, Adamu S, Geng Z, Qiu W, Kostenuik P, Lacey DL, Simonet WS, Bolon B, Qian X, Shalhoub V, Ominsky MS, Zhu Ke H, Li X, Richards WG 2006 Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. Bone 39:754-766
14. Morvan F, Boulukos K, Clément-Lacroix P, Roman Roman S, Suc-Royer I, Vayssière B, Ammann P, Martin P, Pinho S, Pognonec P, Mollat P, Niehrs C, Baron R, Rawadi G 2006 Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res 21:934-945
15. Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, KommBS, Javed A, van Wijnen AJ, Stein JL, Stein GS, Lian JB 2005 Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280:33132-33140
16. Vaes BL, Dechering KJ, Feijen A, Hendriks JM, Lefèvre C, Mummery CL, Olijve W, van Zoelen EJ, Steegenga WT 2002 Comprehensive microarray analysis of bone morphogenetic protein 2-induced osteoblast differentiation resulting in the identification of novel markers for bone development. J Bone Miner Res 17:2106-2118
17. Vaes BL, Dechering KJ, van Someren EP, Hendriks JM, van de Ven CJ, Feijen A, Mummery CL, Reinders MJ, Olijve W, van Zoelen EJ, Steegenga WT 2005 Microarray analysis reveals expression regulation of Wnt antagonists in differentiating osteoblasts. Bone 36: 803-811
18. van Bezooijen RL, Roelen BA, Visser A, van der Wee-Pals L, de Wilt E, Karperien M, Hamersma H, Papapoulos SE, ten Dijke P, Löwik CW 2004 Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med 199:805-814
19. Cadigan KM 2008 Wnt-β-catenin signaling. Curr Biol 18:R943-R947
20. Cadigan KM 2008 Wnt/β-catenin signaling: turning the switch. Dev Cell 14:322-323
21. Chen Y, Whetstone HC, Youn A, Nadesan P, Chow EC, Lin AC, Alman BA 2007 β-Catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. J Biol Chem 282:526-533
22. Kulkarni NH, Halladay DL, Miles RR, Gilbert LM, Frolik CA, Galvin RJ, Martin TJ, Gillespie MT, Onyia JE 2005 Effects of parathyroid hormone on Wnt signaling pathway in bone. J Cell Biochem 95:1178-1190
23. Tobimatsu T, Kaji H, Sowa H, Naito J, Canaff L, Hendy GN, Sugimoto T, Chihara K 2006 Parathyroid hormone increases β-catenin levels through Smad3 in mouse osteoblastic cells. Endocrinology 147:2583-2590
24. Bergenstock MK, Partridge NC 2007 Parathyroid hormone stimulation of noncanonical Wnt signaling in bone. Ann NY Acad Sci 1116:354-359
25. Liu J, Wu X, Mitchell B, Kintner C, Ding S, Schultz PG 2005 A small-molecule agonist of the Wnt signaling pathway. Angew Chem Int Ed Engl 44:1987-1990
26. Kim KK, Ji C, Chang W, Wells RG, Gundberg CM, McCarthy TL, Centrella M 2006 Repetitive exposure to TGF-βsuppresses TGF-β type I receptor expression by differentiated osteoblasts. Gene 379: 175-184
27. Centrella M, Casinghino S, Gundberg C, McCarthy TL, Wozney J, Rosen V 1996 Changes in bone morphogenetic protein sensitivity relative to differentiation in fetal rat bone cell cultures. Ann NY Acad Sci 785:224-226
28. Lian JB, Stein GS, Javed A, van Wijnen AJ, Stein JL, Montecino M, Hassan MQ, Gaur T, Lengner CJ, Young DW 2006 Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metab Disord 7:1-16
29. Ji C, Casinghino S, Chang DJ, Chen Y, Javed A, Ito Y, Hiebert SW, Lian JB, Stein GS, McCarthy TL, Centrella M 1998 CBFa(AML/ PEBP2)-related elements in the TGF-β type I receptor promoter and expression with osteoblast differentiation. J Cell Biochem 69:353-363
30. van Amerongen R, Mikels A, Nusse R 2008 Alternative wnt signaling is initiated by distinct receptors. Sci Signal 1:re9
31. Reinhold MI, Naski MC 2007 Direct interactions of Runx2 and canonical Wnt signaling induce FGF18. J Biol Chem 282:3653-3663
32. Kousteni S, Almeida M, Han L, Bellido T, Jilka RL, Manolagas SC 2007 Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor. Mol Cell Biol 27:1516-1530
33. Centrella M, Casinghino S, Kim J, Pham T, Rosen V, Wozney J, McCarthy TL 1995 Independent changes in type I and type II receptors for transforming growth factor β induced by bone morphogenetic protein 2 parallel expression of the osteoblast phenotype. Mol Cell Biol 15:3273-3281
34. Centrella M, Rosen V, Wozney JM, Casinghino SR, McCarthy TL 1997 Opposing effects by glucocorticoid and bone morphogenetic protein-2 in fetal rat bone cell cultures. J Cell Biochem 67:528-540
35. Ji C, Chen Y, McCarthy TL, Centrella M 1999 Cloning the promoter for transforming growth factor-β type III receptor. Basal and conditional expression in fetal rat osteoblasts. J Biol Chem 274: 30487-30494
36. McCarthy TL, Pham TH, Knoll BI, Centrella M 2007 Prostaglandin E2 increases TGF-β type III receptor expression through CAAT enhancer binding protein δ in osteoblasts. Mol Endocrinol 21:2713-2724
37. Carpenter TO, Moltz KC, Ellis B, Andreoli M, McCarthy TL, Centrella M, Bryan D, Gundberg CM 1998 Osteocalcin production in primary osteoblast cultures derived from normal and Hyp mice. Endocrinology 139:35-43
38. Gutierrez S, Liu J, Javed A, Montecino M, Stein GS, Lian JB, Stein JL 2004 The vitamin D response element in the distal osteocalcin promoter contributes to chromatin organization of the proximal regulatory domain. J Biol Chem 279:43581-43588
39. Milat F, Ng KW 2009 Is Wnt signalling the final common pathway leading to bone formation? Mol Cell Endocrinol 310:52-62
40. Kugimiya F, Kawaguchi H, Ohba S, Kawamura N, Hirata M, Chikuda H, Azuma Y, Woodgett JR, Nakamura K, Chung UI 2007 GSK-3β controls osteogenesis through regulating Runx2 activity. PLoS One 2:e837
41. Ito K, Lim AC, Salto-Tellez M, Motoda L, Osato M, Chuang LS, Lee CW, Voon DC, Koo JK, Wang H, Fukamachi H, Ito Y 2008 RUNX3 attenuates β-catenin/T cell factors in intestinal tumorigenesis. Cancer Cell 14:226-237
42. Letamendia A, Labbe E, Attisano L 2001 Transcriptional regulation by Smads: crosstalk between the TGF-β and Wnt pathways. J Bone Joint Surg Am 83-A(Suppl 1):S31-S39
43. Nawshad A, Lagamba D, Polad A, Hay ED 2005 Transforming growth factor-β signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis. Cells Tissues Organs 179:11-23
44. Clifford RL, Deacon K, Knox AJ 2008 Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor β1: requirement for Smads, β-catenin, and GSK3β. J Biol Chem 283:35337-35353
45. Dong YF, Soung do Y, Chang Y, Enomoto-Iwamoto M, Paris M, O'Keefe RJ, Schwarz EM, Drissi H 2007 Transforming growth factor-β and Wnt signals regulate chondrocyte differentiation through Twist1 in a stage-specific manner. Mol Endocrinol 21: 2805-2820
46. Ji C, Eickelberg O, McCarthy TL, Centrella M 2001 Control and counter-control of TGF-β activity through FAST and Runx (CBFa) transcriptional elements in osteoblasts. Endocrinology 142:3873-3879
47. Chang DJ, Ji C, Kim KK, Casinghino S, McCarthy TL, CentrellaM 1998 Reduction in transforming growth factor βreceptor I expression and transcription factor CBFa1 on bone cells by glucocorticoid. J Biol Chem 273:4892-4896
48. Galindo M, Kahler RA, Teplyuk NM, Stein JL, Lian JB, Stein GS, Westendorf JJ, van Wijnen AJ 2007 Cell cycle related modulations in Runx2 protein levels are independent of lymphocyte enhancerbinding factor 1 (Lef1) in proliferating osteoblasts. J Mol Histol 38:501-506
49. Javed A, Bae JS, Afzal F, Gutierrez S, Pratap J, Zaidi SK, Lou Y, van Wijnen AJ, Stein JL, Stein GS, Lian JB 2008 Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J Biol Chem 283:8412-8422
50. McCarthy TL, Centrella M, Canalis E 1988 Further biochemical and molecular characterization of primary rat parietal bone cell cultures. J Bone Miner Res 3:401-408
51. Centrella M, McCarthy TL, Canalis E 1987 Transforming growth factor β is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem 262:2869-2874
52. Centrella M, Casinghino S, McCarthy TL 1994 Differential actions of prostaglandins in separate cell populations from fetal rat bone. Endocrinology 135:1611-1620
53. Ji C, Casinghino S, McCarthy TL, Centrella M 1997 Multiple and essential Sp1 binding sites in the promoter for transforming growth factor-β type I receptor. J Biol Chem 272:21260-21267
54. Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B, Kern SE 1998 Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1:611-617
55. McCarthy TL, Chang WZ, Liu Y, Centrella M 2003 Runx2 integrates estrogen activity in osteoblasts. J Biol Chem 278:43121-43129
56. McCarthy TL, Ji C, Chen Y, Kim KK, Imagawa M, Ito Y, Centrella M 2000 Runt domain factor (Runx)-dependent effects on CCAAT/ enhancer-binding protein δ expression and activity in osteoblasts. J Biol Chem 275:21746-21753
57. McCarthyTL,HochbergRB,LabareeDC,Centrella M 2007 3-ketosteroid reductase activity and expression by fetal rat osteoblasts. J Biol Chem 282:34003-34012
58. Centrella M, McCarthy TL, Chang WZ, Labaree DC, Hochberg RB 2004 Estren (4-estren-3α,17β-diol) is a prohormone that regulates both androgenic and estrogenic transcriptional effects through the androgen receptor. Mol Endocrinol 18:1120-1130